An act relating to prescriptions for psychotropic medications used by children and youth in the Dr. Dynasaur program

H 305 requires enhanced oversight and informed consent procedures for prescriptions of psychotropic medications (medications for mental health conditions) given to children and youth enrolled in Vermont's Dr. Dynasaur program. The bill mandates that healthcare providers obtain specific, documented consent from parents or guardians before prescribing these medications and establishes clearer accountability measures for monitoring their use. This directly affects children in the Dr. Dynasaur program, their families, and the healthcare providers prescribing these medications. The bill aims to strengthen safeguards around medication management for vulnerable youth without specifying new treatment protocols. (Introduced February 2025, currently before the Health Care Committee.)